PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151,100 | -1.9% | 350,342 | 0.0% | 0.42% | -4.5% |
| Q2 2023 | $2,193,141 | -16.5% | 350,342 | -36.3% | 0.44% | -17.9% |
| Q1 2023 | $2,625,131 | -45.2% | 550,342 | 0.0% | 0.54% | -46.5% |
| Q4 2022 | $4,787,975 | -26.9% | 550,342 | 0.0% | 1.01% | -38.4% |
| Q3 2022 | $6,549,000 | -16.5% | 550,342 | 0.0% | 1.64% | -10.5% |
| Q2 2022 | $7,842,000 | +7.5% | 550,342 | +57.1% | 1.84% | +27.9% |
| Q1 2022 | $7,294,000 | -42.6% | 350,342 | -36.3% | 1.44% | -39.6% |
| Q4 2021 | $12,713,000 | +20.1% | 550,342 | +54.9% | 2.38% | +9.7% |
| Q3 2021 | $10,589,000 | -19.6% | 355,342 | -7.8% | 2.17% | -19.5% |
| Q2 2021 | $13,163,000 | -53.2% | 385,342 | -54.9% | 2.70% | -55.6% |
| Q1 2021 | $28,111,000 | – | 854,684 | – | 6.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |